Gainers

• HTG Molecular Diagnostics, Inc. HTGM shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
• Harpoon Therapeutics, Inc. HARP rose 97.3% to $2.27 after the company announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
• Tonix Pharmaceuticals Holding Corp. TNXP gained 85% to $0.69 after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2 monoclonal antibodies from Curia Global.
• Aptevo Therapeutics Inc. APVO shares climbed 65.6% to $5.68 after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
• Faraday Future Intelligent Electric Inc. FFIE rose 56.2% to $0.4612 after gaining over 11% on Friday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company, effectively immediately.
• China Jo-Jo Drugstores, Inc. CJJD jumped 39.9% to $4.63 after jumping 53% on Friday.
• Dragonfly Energy Holdings Corp. DFLI surged 34.5% to $14.80.
• Virax Biolabs Group Limited VRAX jumped 28.7% to $1.30.
• United Insurance Holdings Corp. UIHC gained 28.3% to $0.4297. The company, last month, posted downbeat quarterly results.
• Reborn Coffee, Inc. REBN rose 28.3% to $1.3602 after jumping around 22% on Friday. Reborn Coffee recently signed a Letter of Intent to acquire a specialty coffee shop and a roasting research and development facility in Daejeon, South Korea as a part of its global expansion plan.
• Coupa Software Incorporated COUP shares gained 26.6% to $78.63 after the company announced it will be acquired by Thoma Bravo for $8 billion.
• BIMI International Medical, Inc. BIMI gained 25% to $2.60. BIMI recently announced a 1-for-10 reverse stock split.
• Weber Inc. WEBR jumped 24.9% to $8.12 after the company entered an agreement to be taken private by BDT Capital Partners for $8.05 per share.
• Avalon GloboCare Corp. ALBT gained 24.4% to $0.3980. Avalon GloboCare announced a new proposed board composition in preparation for acquisition of Laboratory Services MSO, LLC.
• Kingstone Companies, Inc. KINS jumped 22% to $1.33.
• Bruush Oral Care Inc. BRSH shares rose 21.6% to $0.59. Bruush Oral Care reported closing of $3.0 million private placement.
• EZFill Holdings Inc. EZFL gained 19% to $0.46. EzFill Holdings, last month, posted a Q3 loss of $0.15 per share.
• Chemomab Therapeutics Ltd. CMMB jumped 15% to $2.7601.
• Horizon Therapeutics Public Limited Company HZNP rose 14.6% to $111.48 after Amgen announced it will acquire the company for $116.50 per share in cash.
• Studio City International Holdings Limited MSC gained 14% to $5.33.
• Aerovate Therapeutics, Inc. AVTE jumped 13.7% to $28.20.
• 111, Inc. YI gained 13% to $3.73. 111 recently posted Q3 adjusted loss of $0.10 per share.
• Oriental Culture Holding LTD OCG gained 12.9% to $0.8355.
• China SXT Pharmaceuticals, Inc. SXTC rose 11.5% to $0.6471 after gaining over 20% on Friday.
• Connexa Sports Technologies Inc. CNXA gained 10.8% to $0.18.
• Cogent Biosciences, Inc. COGT jumped 10.7% to $12.29 after the company announced updated clinical data from ongoing Phase 2 APEX trial evaluating bezuclasttinib in patients with advanced systemic mastocytosis.
• Pitney Bowes Inc. PBI jumped 9.4% to $4.19. Hestia Capital confirmed intent to overhaul Pitney Bowes’ board of directors following 10+ years of significant value destruction under Chair Michael Roth and CEO Marc Lautenbach.
• Frontline Ltd. FRO gained 8.8% to $13.95. Frontline, last week, issued a Form424B3 filing highlighting a proposal to increase the company’s authorized share capital from $500 million to $600 million.
• HashiCorp, Inc. HCP jumped 7.6% to $31.87. HashiCorp recently reported better-than-expected Q3 sales results.

Losers

• Affimed NV. AFMD fell 39.2% to $1.24 after the company announced topline data from its Phase 2 REDIRECT study of AFM13 monotherapy in patients with advanced-stage relapsed/refractory peripheral T cell lymphoma.
• Ambrx Biopharma Inc. AMAM fell 38.3% to $2.7991. Ambrx Biopharma shares jumped over 1,007% on Friday after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
• Adicet Bio, Inc. ACET shares fell 37.2% to $10.85 after the company announced safety and efficacy data from its ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell NHL.
• Rockley Photonics Holdings Limited RKLY dropped 34.8% to $0.2601.
• TeraWulf Inc. WULF dipped 31% to $0.8388. TeraWulf increased expected Q1 2023 self-mining hash rate at no additional cost and announced repayment of certain debt.
• SHF Holdings, Inc. SHFS fell 26.6% to $2.43.
• Curis, Inc. CRIS fell 25.1% to $0.5744 after the company announced additional clinical data from TakeAim Leukemia study of emavusertib in monotherapy R/R AML and hrMDS.
• Fangdd Network Group Ltd. DUO dropped 23.2% to $0.9369. Xi Zeng recently disclosed a 6.5% active stake in Fangdd Network Group Ltd.
• Appreciate Holdings, Inc. SFR declined 20.3% to $2.20.
• Inotiv, Inc. NOTV fell 20.2% to $4.5350 after the company issued FY22 sales guidance below estimates.
• Baudax Bio, Inc. XRX shares fell 16.8% to $4.3261. Baudax Bio shares gained around 28% on Friday after the company announced initiation of a Phase II clinical trial evaluation of BX1000 in patients undergoing surgery.
• HUYA Inc. HUYA fell 16.3% to $2.9050. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
• TAL Education Group TAL dipped 16% to $5.55.
• Baozun Inc. BZUN fell 15.3% to $4.91. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
• DouYu International Holdings Limited DOYU dropped 14.9% to $1.2850. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
• Fate Therapeutics, Inc. FATE fell 14.6% to $16.10. GT Biopharma and Fate Therapeutics presented preclinical data highlighting novel dual antigen targeting approach for the treatment of AML at ASH 2022.
• Dada Nexus Limited DADA dropped 14% to $6.34. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
• UpHealth, Inc. UPH fell 13.5% to $2.1180.
• Lufax Holding Ltd LU declined 13.4% to $1.9909. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
• Hello Group Inc. MOMO dropped 13.2% to $7.75.
• Hillstream BioPharma, Inc. HILS fell 11.5% to $0.5389 after climbing 43% on Friday. Hillstream BioPharma recently company announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
• Meta Materials Inc. MMAT fell 11.3% to $1.26 after dipping 22% on Friday. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META’s Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
• Ensysce Biosciences, Inc. ENSC shares fell 10.8% to $1.07 after jumping 21% on Friday. Ensysce Biosciences recently announced pricing of a $4.1 million public offering.
• Panbela Therapeutics, Inc. PBLA fell 7.2% to $0.0917.

Also check this out Bitcoin Drops But Remains Above This Key Level; Chiliz, Dogecoin Among Top Losers.